Menu
Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 6 » default
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438
- View all (258)
- Volume 15, 2023 (3)
- Volume 14, 2022 (12)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Archive: Volume 6, 2014
Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms
Hermann R, Mungo J, Cnota PJ, Ziegler D
Clinical Pharmacology: Advances and Applications 2014, 6:195-204
Published Date: 28 November 2014
Parkinson's disease: carbidopa, nausea, and dyskinesia
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2014, 6:189-194
Published Date: 14 November 2014
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Clinical Pharmacology: Advances and Applications 2014, 6:179-187
Published Date: 13 November 2014
Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal
Lizotte RJ, Kappes JA, Bartel BJ, Hayes KM, Lesselyoung VL
Clinical Pharmacology: Advances and Applications 2014, 6:171-177
Published Date: 31 October 2014
The Parkinson's disease death rate: carbidopa and vitamin B6
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2014, 6:161-169
Published Date: 21 October 2014
Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study
Tompson DJ, Crean CS, Buraglio M, Arumugham T
Clinical Pharmacology: Advances and Applications 2014, 6:149-159
Published Date: 13 October 2014
Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens
Matsumoto T
Clinical Pharmacology: Advances and Applications 2014, 6:139-148
Published Date: 26 September 2014
Melatonergic drugs in development
Carocci A, Catalano A, Sinicropi MS
Clinical Pharmacology: Advances and Applications 2014, 6:127-137
Published Date: 18 September 2014
Reducing medication errors in critical care: a multimodal approach
Kruer RM, Jarrell AS, Latif A
Clinical Pharmacology: Advances and Applications 2014, 6:117-126
Published Date: 1 September 2014
Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
Pacifici GM
Clinical Pharmacology: Advances and Applications 2014, 6:111-116
Published Date: 31 July 2014
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2014, 6:107-110
Published Date: 22 July 2014
Effect of age and sex on warfarin dosing
Khoury G, Sheikh-Taha M
Clinical Pharmacology: Advances and Applications 2014, 6:103-106
Published Date: 12 July 2014
In vitro microdialysis membrane efficiency of broad-spectrum antibiotics in combination and alone
MacVane SH, Housman ST, Nicolau DP
Clinical Pharmacology: Advances and Applications 2014, 6:97-101
Published Date: 5 June 2014
Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
Harvey RD
Clinical Pharmacology: Advances and Applications 2014, 6:87-96
Published Date: 8 May 2014
Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
Nakamura M, Sasai N, Hisatome I, Ichida K
Clinical Pharmacology: Advances and Applications 2014, 6:79-86
Published Date: 3 May 2014
Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization
Kose E, An T, Kikkawa A, Matsumoto Y, Hayashi H
Clinical Pharmacology: Advances and Applications 2014, 6:71-78
Published Date: 8 April 2014
Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study
Rambiritch V, Maharaj B, Naidoo P
Clinical Pharmacology: Advances and Applications 2014, 6:63-69
Published Date: 4 April 2014
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]
Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C
Clinical Pharmacology: Advances and Applications 2014, 6:61-62
Published Date: 27 March 2014
Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers
Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T
Clinical Pharmacology: Advances and Applications 2014, 6:51-59
Published Date: 19 March 2014
Population pharmacokinetics of olprinone in healthy male volunteers
Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H
Clinical Pharmacology: Advances and Applications 2014, 6:43-50
Published Date: 4 March 2014
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways
Arnold P, Mojumder D, DeToledo J, Lucius R, Wilms H
Clinical Pharmacology: Advances and Applications 2014, 6:35-42
Published Date: 24 February 2014
The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders
Gao B, Doan A, Hybertson BM
Clinical Pharmacology: Advances and Applications 2014, 6:19-34
Published Date: 3 February 2014
Chronic hepatitis C: future treatment
Wendt A, Adhoute X, Castellani P, Oules V, Ansaldi C, Benali S, Bourlière M
Clinical Pharmacology: Advances and Applications 2014, 6:1-17
Published Date: 8 January 2014